MedTrace Logo

Revealed Versus Concealed Cerebroplacental Ratio

NCT02907242 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11582

Last updated 2022-04-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the role of an integrated strategy at selecting fetuses for delivery at term based on a combination of fetal biometry and cerebroplacental ratio (CPR) to reduce stillbirth rate and adverse perinatal outcome.

Conditions

  • Stillbirth

Interventions

OTHER

Revealment

Cerebroplacental ratio revealment

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    lead OTHER

Principal Investigators

  • Eduard Gratacos, PhD · Hospital Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-04
Primary Completion
2022-01-06
Completion
2022-01-06

Countries

  • Chile
  • Czechia
  • Israel
  • Mexico
  • Poland
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02907242 on ClinicalTrials.gov